TWO · Healthcare

Singbao International Co Ltd (6130)

Drug Manufacturers - General

Singbao International Co Ltd (6130) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6130

P/E ratio

18.00

Singbao International Co Ltd (6130) — FAQ

What is 6130's P/E ratio?

The price-to-earnings (P/E) ratio for Singbao International Co Ltd (6130) is 18.00 (data as of 2026-05-23).

Does Singbao International Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Singbao International Co Ltd (6130). Check the MyAverix Finance app for the latest dividend data.

What sector is Singbao International Co Ltd in?

Singbao International Co Ltd (6130) is classified in the Healthcare sector (Drug Manufacturers - General industry).

What exchange is 6130 listed on?

6130 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)